OpenBilldrug price receipt

NADAC week of 2026-10-14

AZELASTINE 0.1% (137 MCG) SPRY

For 1 mL

Pharmacies pay

$0.27 filed

1 × $0.27283 per ML

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$1.07 filed

1 × $1.07152 per ML, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

The spread

3.9× estimated

Medicare paid 3.9× what pharmacies pay.

Part D averages every strength and form sold under “Azelastine HCl*” / “Azelastine HCl” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$5.31 estimated

$0.27 + $0.04 (15%) + $5.00 fee per fill = $5.31

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

AZELASTINE 0.1% (137 MCG) SPRY is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “azelastine hydrochloride” and “azelastine”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as spray, metered and its route as nasal.

FDA lists 5 labelers (the companies named on the label) for its NDCs, among them Aurobindo Pharma Limited, Apotex Corp. and Amneal Pharmaceuticals LLC.

FDA’s Established Pharmacologic Class for it is Histamine-1 Receptor Antagonist.

The NADAC file of 2026-10-14 prices it under 5 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $0.27 for 1 mL (1 × $0.27283 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

What NADAC measures · NADAC explanation codes

All 5 NDCs

Other strengths, forms and brands

1 other product in the NADAC file shares an FDA nonproprietary name with AZELASTINE 0.1% (137 MCG) SPRY.

ProductPharmacies pay per unitMedicare per unit
AZELASTINE 0.1% (137 MCG) SPRY this page
generic · spray, metered		$0.27283 per ML filed
eff. 2026-09-23		$1.07152 per ML filed
Part D 2024 average
AZELASTINE HCL 0.05% DROPS
generic · solution/ drops		$1.01239 per ML filed
eff. 2026-09-23		We don’t know yet

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 5 NDCs’ NADAC prices is $0.27283 per ML filed.

Of the 46 other products in FDA’s Histamine-1 Receptor Antagonist class priced per ML, 19 have a higher middle NADAC price and 27 a lower one. The one in the middle is ITCH RELIEF 2%-0.1% SPRAY, at $0.04712 per ML filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

Medicare Part D paid $1.07 for 1 mL, at an average of $1.07152 per ML in 2024 (2024-01-01 to 2024-12-31) for “Azelastine HCl*” and “Azelastine HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 3,263,509 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for AZELASTINE 0.1% (137 MCG) SPRY labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Azelastine HCl* / Azelastine HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's ML. Joined on generic name. *: CMS says this average reflects multiple routes of administration, which may have different unit prices. Only NADAC NDCs whose FDA route includes NASAL point at this name (5 of the 10 the name join matched); NDCs of another route or with no known FDA route do not.
Why does this page start at 1 mL?
The FDA package description of NDC 59651-0214-30 (“1 BOTTLE, SPRAY in 1 CARTON (59651-214-30) / 200 SPRAY, METERED in 1 BOTTLE, SPRAY”) does not give one amount in mL, NADAC’s unit for this product. So the card starts at 1 ML; change it to match your prescription.

Its pharmacologic class

Related in the same class

More